Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase III trial investigating the efficacy of an encapsulated cell therapy product [NovaCaps] versus gemcitabine for advanced, inoperable pancreatic cancer

Next Previous
Trial Profile

Phase III trial investigating the efficacy of an encapsulated cell therapy product [NovaCaps] versus gemcitabine for advanced, inoperable pancreatic cancer

Status: Planning
Phase of Trial: Phase III

Latest Information Update: 07 Nov 2016

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 24 Oct 2016 According to a PharmaCyte Biotech media release, Manuel Hidalgo, MD, PhD has agreed to serve as the Principal Investigator for this trial.
  • 04 Nov 2013 Cloning of the cancer-drug-activating cells required for phase 3 clinical trials has begun at Inno Biologics, according to a Nuvilex media release.
  • 19 Sep 2013 Inno Biologics will generate cell clones for production of microencapsulated CYP-2B1-expressing cells for this trial, and Fisher BioServices will store them, according to a Nuvilex media release.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top